Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

NARecruitingINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

July 25, 2025

Primary Completion Date

December 31, 2031

Study Completion Date

July 31, 2032

Conditions
Hiatal Hernia
Interventions
DEVICE

OviTex Reinforced Tissue Matrix

All study subjects will receive OviTex. All OviTex Reinforced Tissue Matrices are intended for use as a surgical mesh to reinforce or repair soft tissue where weakness exists.

Trial Locations (2)

36617

RECRUITING

University of South Alabama Health, Mobile

78712

RECRUITING

The University of Texas at Austin - Dell Medical School, Austin

All Listed Sponsors
lead

Tela Bio Inc

INDUSTRY

NCT07070115 - Evaluating Clinical Hiatal Hernia Outcomes Using OviTex® | Biotech Hunter | Biotech Hunter